BamSEC and AlphaSense Join Forces
Learn More

Inhibikase Therapeutics Inc.

NASDAQ: IKT    
Share price (12/20/24): $3.20    
Market cap (12/20/24): $215 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.5
from 8-K 6 pages Settlement Agreement
12/34/56
EX-10.4
from 8-K 5 pages Email Only [•], 2024 [Name] Re: Director Offer Letter [•], This Director Offer Letter Constitutes an Agreement (“Agreement”) Between You and Inhibikase Therapeutics, Inc. (“Company”) and Contains All of the Terms and Conditions Relating to Your Service to the Company as a Class [•] Member of Our Board of Directors (“Board”)
12/34/56
EX-10.3
from 8-K 9 pages Support Agreement
12/34/56
EX-10.2
from 8-K 23 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 47 pages Securities Purchase Agreement
12/34/56
EX-10.20
from S-1 5 pages Support Agreement
12/34/56
EX-10.19
from S-1 2 pages Form of Lock-Up Agreement
12/34/56
EX-10.3
from 8-K 10 pages To the Holder of January 2023 Common Stock Purchase Warrants Re: Inducement Offer to Exercise Existing Common Stock Purchase Warrants Dear Holder
12/34/56
EX-10.2
from 8-K 7 pages Placement Agency Agreement
12/34/56
EX-10.1
from 8-K 38 pages Securities Purchase Agreement
12/34/56
EX-10.19
from S-1/A 34 pages Securities Purchase Agreement
12/34/56
EX-10.19
from S-1/A 34 pages Securities Purchase Agreement
12/34/56
EX-10.18
from S-1 23 pages Inhibikase Therapeutics, Inc. Employment Agreement
12/34/56
EX-10.1
from 8-K 44 pages At the Market Offering Agreement February 1, 2024
12/34/56
EX-10.3
from 8-K 29 pages Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 41 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 41 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 5 pages Re: Director Offer Letter Dear Gisele, This Director Offer Letter Constitutes an Agreement (“Agreement”) Between You and Inhibikase Therapeutics, Inc. (“Company”) and Contains All of the Terms and Conditions Relating to Your Service to the Company as a Class II Member of Our Board of Directors (“Board”)
12/34/56
EX-10.1
from 8-K 46 pages Inhibikase Therapeutics, Inc. Equity Distribution Agreement
12/34/56
EX-10.3
from 8-K 5 pages Inhibikase Therapeutics, Inc. 2020 Equity Incentive Plan Stock Option Grant Notice and Award Agreement
12/34/56